Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones
Free Radic Biol Med. 2009 Jan 15;46(2):253-62.
Gaikwad NW, Yang L, Rogan EG, Cavalieri EL.
NQO2 is a newly discovered binding site (MT3) of melatonin, indicating that it could be a novel target for prevention of breast cancer initiation.
Quinone oxidoreductase 2 (NQO2).